Columbia China has reopened the 232-bed Shanghai Kaiyuan Orthopedic Hospital as an Orthopaedic Centre of Excellence.
Columbia China spent USD75 million (RMB500 million) to acquire and retrofit the Kaiyuan hospital in Shanghai’s Pudong District.
The reopening is part of Columbia China’s plans to expand in China through both acquisitions and greenfield projects and to provide China’s growing middle-class population with affordable, patient-centred care across a spectrum of healthcare and senior services.
“While we aggressively develop our own hospitals from the ground up, we are also always looking for opportunities to acquire hospitals and use our decades of healthcare experience to upgrade the building, services, technology and training to international standards,” says Nate McLemore, managing director of Columbia Pacific Management, one of Columbia China’s parent companies.
After buying the Kaiyuan hospital last year, Columbia China hired Dr Wu Haishan, one of China’s most well-known orthopaedic surgeons, as president of the newly acquired hospital. Wu retired last year from the public health system after more than 30 years. He most recently served as chief physician of the Orthopaedics department at Shanghai Changzheng Hospital, and as professor of joint surgery at the Second Military Medical University in Shanghai.
Columbia China’s retrofit of the Kaiyuan hospital expanded it from 200 to 232 beds and from four to six operating theatres, and added a new facade, lobby, all new inpatient and outpatient rooms, rehabilitation areas and upgraded equipment, including new MRI and CT scanners.
“The Shanghai Kaiyuan Orthopedic Hospital is positioned to be the Orthopaedic Centre of Excellence in joint, spine, minimally invasive surgeries and sports medicine, with the highest standards recognised around the world,” says Bee Lan Tan, president and group CEO of Columbia China.
